By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Celator Pharmaceuticals, Inc. 

303B College Road East

Princeton  New Jersey  08540  U.S.A.
Phone: 609-243-0123 Fax: 609-243-0202


Company News
Former Celator (CPXX) CPA Connived With Two Friends, Father on Insider-Trading Scheme 9/1/2017 5:29:57 AM
FDA Berates Celator Pharma (CPXX) for Pushing Unapproved Leukemia Drug to Doctors 9/8/2016 6:48:22 AM
Jazz Pharma (JAZZ) Announces Results Of Tender Offer To Purchase All Of The Outstanding Shares Of Common Stock Of Celator Pharma (CPXX) 7/12/2016 6:07:36 AM
Jazz Pharma (JAZZ) Announces Expiration Of HSR Waiting Period For Proposed Celator Pharma (CPXX) Acquisition 6/27/2016 8:29:03 AM
Celator Pharma (CPXX) Announces Positive Results In Patients With FLT3 Mutation From The Phase 3 Trial In High-Risk Acute Myeloid Leukemia 6/15/2016 9:35:13 AM
ASCO2016: Celator Pharma (CPXX) Presented Phase 3 Trial Results In Patients With High-Risk Acute Myeloid Leukemia Demonstrating VYXEOS (CPX-351) Significantly Improved Overall Survival 6/6/2016 9:05:22 AM
2 Stocks Billionaires Who Made a Killing Off of Celator Pharma (CPXX) are Buying 6/2/2016 7:13:50 AM
Celator Pharma (CPXX) Cancels Analyst And Investor Meeting And Postpones Annual Meeting Of Stockholders 6/1/2016 11:35:17 AM
Jazz Pharma (JAZZ) Pays $1.5 Billion for Celator Pharma (CPXX) to Gain a Promising Leukemia Drug 5/31/2016 6:03:49 AM
Celator Pharma (CPXX) Announces Upcoming Phase 3 Data Presentations At ASCO And European Hematology Association 5/20/2016 6:19:16 AM